We are live on ! Find out more
AI

Alphabet Inc Portfolio holdings

AUM $4.02B
1-Year Est. Return 215.74%
This Fund
S&P 500
This Quarter Est. Return
-25.76%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$1.84B
AUM Growth
-$1.24B
Cap. Flow
-$319M
Cap. Flow %
-17.29%
Top 10 Hldgs %
78.72%
Holding
62
New
2
Increased
Reduced
2
Closed
7

Top Buys

Rank Stock Value
1
GTLB icon
GitLab
GTLB
+$27.6M
2
VLD
Velo3D, Inc.
VLD
+$17.9M

Top Sells

Rank Stock Value
1
IONQ icon
IonQ
IONQ
+$280M
2
RCUS icon
Arcus Biosciences
RCUS
+$80.9M
3
DXCM icon
DexCom
DXCM
+$1.3M
4
TWLO icon
Twilio
TWLO
+$611K
5
NXDR
Nextdoor Holdings
NXDR
+$583K

Sector Composition

Rank Sector Weight
1 Healthcare 57.09%
2 Technology 28.81%
3 Industrials 9.28%
4 Consumer Staples 2.28%
5 Financials 2.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DXCM icon
1
DexCom
DXCM
$27.6B
$312M 16.94%
4,188,154
-14,226
-0.3% -$1.3M
PATH icon
2
UiPath
PATH
$5.62B
$256M 13.89%
14,068,674
EQRX
3
DELISTED
EQRx, Inc. Common Stock
EQRX
$223M 12.1%
47,552,687
VERV
4
DELISTED
Verve Therapeutics
VERV
$168M 9.1%
10,974,011
PL icon
5
Planet Labs
PL
$7.3B
$138M 7.51%
31,942,641
OSCR icon
6
Oscar Health
OSCR
$8.5B
$102M 5.55%
24,042,864
LYFT icon
7
Lyft
LYFT
$5.39B
$81.5M 4.42%
6,138,154
SNOW icon
8
Snowflake
SNOW
$92.9B
$74.5M 4.04%
535,604
FRSH icon
9
Freshworks
FRSH
$2.84B
$53.1M 2.88%
4,035,595
BHIL
10
DELISTED
Benson Hill, Inc.
BHIL
$42.1M 2.28%
438,636
HOOD icon
11
Robinhood
HOOD
$85.2B
$40.5M 2.2%
4,928,535
LYEL icon
12
Lyell Immunopharma
LYEL
$309M
$38.2M 2.08%
293,256
GTLB icon
13
GitLab
GTLB
$5.28B
$31.5M 1.71%
+593,404
New +$27.6M
RLAY icon
14
Relay Therapeutics
RLAY
$4.02B
$26.3M 1.43%
1,568,753
DM
15
DELISTED
Desktop Metal, Inc.
DM
$24.3M 1.32%
1,104,873
IVVD icon
16
Invivyd
IVVD
$180M
$18.6M 1.01%
5,680,785
TOST icon
17
Toast
TOST
$16.8B
$18.5M 1.01%
1,432,660
SANA icon
18
Sana Biotechnology
SANA
$885M
$18.1M 0.98%
2,812,500
ME
19
DELISTED
23andMe Holding Co
ME
$16.7M 0.91%
336,839
GLUE icon
20
Monte Rosa Therapeutics
GLUE
$1.92B
$14.2M 0.77%
1,464,015
DUOL icon
21
Duolingo
DUOL
$5.7B
$12.6M 0.69%
144,444
BEAM icon
22
Beam Therapeutics
BEAM
$2.58B
$12.4M 0.68%
321,604
IDYA icon
23
IDEAYA Biosciences
IDYA
$3.41B
$10.4M 0.56%
753,187
RAPT
24
DELISTED
RAPT Therapeutics
RAPT
$9.86M 0.54%
67,534
ILMN icon
25
Illumina
ILMN
$29.4B
$9.86M 0.54%
54,967

Similar funds

Alphabet Inc's Q2 2022 Portfolio in Review

As of Q2 2022, Alphabet Inc held 62 positions worth $1.84B, down 40% from $3.08B the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Alphabet Inc withdrew a net $319M in Q2 2022, closing 7 positions and reducing 2 holdings. Its most notable exit was IonQ, an estimated $280M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 54% a quarter earlier, followed by Technology and Industrials.

Against the trend, Alphabet Inc opened a new position in GitLab worth $31.5M.

  • Alphabet Inc's largest Q2 2022 buy was GitLab: 593,404 shares worth $31.5M.
  • Alphabet Inc's biggest Q2 2022 reduction was DexCom, cutting an estimated $1.3M.
  • Alphabet Inc fully exited IonQ in Q2 2022, selling an estimated $280M.
  • Alphabet Inc's ten largest holdings make up 79% of its $1.84B portfolio in Q2 2022.
  • Alphabet Inc opened 2 new positions and closed 7 in Q2 2022.
  • Alphabet Inc's portfolio value fell 40% quarter-over-quarter to $1.84B.

Based on Alphabet Inc's 13F filing for Q2 2022, filed 15 Nov 2022.